000			01818 a2200493 4500
005			20250514210355.0
264		0	_c20041217
008			200412s 0 0 eng d
022			_a0022-1767
024	7		_a10.4049/jimmunol.173.10.6082 _2doi
040			_aNLM _beng _cNLM
100	1		_aKodali, Sreedevi
245	0	0	_aVasoactive intestinal peptide modulates Langerhans cell immune function. _h[electronic resource]
260			_bJournal of immunology (Baltimore, Md. : 1950) _cNov 2004
300			_a6082-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAnimals
650	0	4	_aAntigen Presentation _ximmunology
650	0	4	_aCell Line
650	0	4	_aCell Line, Tumor
650	0	4	_aClone Cells
650	0	4	_aDown-Regulation _ximmunology
650	0	4	_aFemale
650	0	4	_aHypersensitivity, Delayed _xprevention & control
650	0	4	_aImmunity, Innate _ximmunology
650	0	4	_aImmunologic Factors _xpharmacology
650	0	4	_aInterleukin-1 _xantagonists & inhibitors
650	0	4	_aInterleukin-10 _xbiosynthesis
650	0	4	_aInterleukin-12 _xantagonists & inhibitors
650	0	4	_aLangerhans Cells _ximmunology
650	0	4	_aMice
650	0	4	_aMice, Inbred A
650	0	4	_aMice, Inbred BALB C
650	0	4	_aT-Lymphocytes _ximmunology
650	0	4	_aUp-Regulation _ximmunology
650	0	4	_aVasoactive Intestinal Peptide _xpharmacology
700	1		_aDing, Wanhong
700	1		_aHuang, Jing
700	1		_aSeiffert, Kristina
700	1		_aWagner, John A
700	1		_aGranstein, Richard D
773	0		_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 173 _gno. 10 _gp. 6082-8
856	4	0	_uhttps://doi.org/10.4049/jimmunol.173.10.6082 _zAvailable from publisher's website
999			_c15216085 _d15216085